# EDGAR Filing Document

**Accession Number:** 0001596812
**File Stem:** 0001213900-26-048375
**Filing Date:** 2026-4
**Character Count:** 2379
**Document Hash:** f8a4f2ee0c0306bd5f520ce5f3cd3d8e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-048375.hdr.sgml**: 20260529

**ACCESSION NUMBER**: 0001213900-26-048375

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260428

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Enlivex Ltd.
- **CENTRAL INDEX KEY:** 0001596812
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 37 DEREH MENACHEM BEGIN ST.
- **STREET 2:** 15TH FLOOR
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3
- **BUSINESS PHONE:** 972 (0) 3 7326616

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 37 DEREH MENACHEM BEGIN ST.
- **STREET 2:** 15TH FLOOR
- **CITY:** TEL AVIV
- **PROVINCE COUNTRY:** L3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Enlivex Therapeutics Ltd.
- **DATE OF NAME CHANGE:** 20190326

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bioblast Pharma Ltd.
- **DATE OF NAME CHANGE:** 20160919

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIO BLAST PHARMA LTD.
- **DATE OF NAME CHANGE:** 20140113

**Enlivex Ltd.**

14 Einstein Street

Ness Ziona

Israel 7403618

April 28, 2026

**<u>VIA EDGAR</u>**<br> United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Attention: Tyler Howes

---

| | |
|:---|:---|
| **RE:** | **Enlivex Ltd. (the "Company")** |

---

**Registration Statement on Form F-3 (the "Registration Statement")**

**Filed April 21, 2026**

**File No. 333-295215** 

Dear Mr. Howes:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. on April 30, 2026, or as soon thereafter as practicable.

[Signature page follows]

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| **Enlivex Ltd.** | **Enlivex Ltd.** | **Enlivex Ltd.** |
| By: | /s/ Oren Hershkovitz | /s/ Oren Hershkovitz |
|  | Name: | Oren Hershkovitz |
|  | Title: | Chief Executive Officer |

---